FTC Backs Cardinal Health's Nuclear Pharmacy Sale Plan
The Federal Trade Commission has signed off on the sales of three nuclear pharmacies that Cardinal Health Inc. was required to divest after acquiring Biotech Pharmacy Inc., the agency said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article